Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis

Summary

The investigators hypothesize that the inhibition of endogenous reverse transcriptase would: (1) reduce excess cytosolic DNA, stress initiating the inflammatory loop at the origin of psoriatic lesions, and (2) interrupt the loop and lighten lesions

Timeline

Start

2020-02-13

Primary completion

2021-11-29

Completion

2022-06-20

Drugs

Indications